MicroRNA signatures in genetic frontotemporal dementia and amyotrophic lateral sclerosis

OBJECTIVE: MicroRNAs are promising biomarkers of frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS), but discrepant results between studies have so far hampered their use in clinical trials. We aim to assess all previously identified circulating microRNA signatures as potential bi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kmetzsch, Virgilio, Latouche, Morwena, Saracino, Dario, Rinaldi, Daisy, Camuzat, Agnès, Gareau, Thomas, Le Ber, Isabelle, Colliot, Olivier, Becker, Emmanuelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639633/
https://www.ncbi.nlm.nih.gov/pubmed/36264717
http://dx.doi.org/10.1002/acn3.51674

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639633/
https://www.ncbi.nlm.nih.gov/pubmed/36264717
http://dx.doi.org/10.1002/acn3.51674

Ejemplares similares